Programme | Speaker |
---|---|
Welcome and introduction | Chair: Elie Haddad (Montreal, Canada) |
Case 1: Unmasking PID in a SID patient with haematological malignancy | Stephen Jolles (Cardiff, UK) |
Case 2: A surprising diagnosis | Elie Haddad (Montreal, Canada) |
Case 3: Could neuropsychiatric disorders PANS/PANDAS be associated with PID? | Michael Daines (Tucson, Arizona, USA) |
Closing Remarks | Elie Haddad (Montreal, Canada) |
IPIC Congress 2023 - Octapharma Symposium
Clinical Cases: Uncovering atypical manifestations of PID
Register here
If you are interested in joining this symposium, register to the IPIC congress and pre-register yourself above to attend the session!
Summary of the session
Classical immunodeficiencies are mainly characterized by infectious conditions. Although in the recent years manifestations related to allergy, inflammation, autoimmunity, lymphoproliferation, and malignancies have been described, it can be difficult to unravel the relationship between primary immunodeficiencies (PID), secondary immunodeficiencies (SID) and hematological malignancy or autoimmunity in the clinical setting. During this session, the audience will actively participate in the discussion around interactive clinical cases showcasing atypical manifestations of PID with various clinical presentations.
Symposium programme
Clinical Cases: Uncovering atypical manifestations of PID
Friday, 10 November 2023
13:45 - 14:45 CET
Room: Rotterdam Hall
This scientific information may include data/information on investigational uses of compounds/drugs that have not yet been approved by regulatory authorities. This program was developed for use outside the U.S., is intended for non-U.S. HCPs, and is to be used in accordance with local laws and regulations.
Speakers panel
Learn more about the IPIC 2023 congress
Come and explore the Octapharma Science Hub